nach oben

NeuroMolecular Medicine

Erschienen in:

01.03.2013 | Original Paper

Identification of a Novel ANKK1 and Other Dopaminergic (DRD2 and DBH) Gene Variants in Migraine Susceptibility

verfasst von: Jayashri Ghosh, Sunil Pradhan, Balraj Mittal

Erschienen in: NeuroMolecular Medicine | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The dopaminergic system plays an important role in migraine and its clinical subtypes. Hypersensitization of dopamine receptor type 2 (DRD2) in migraine led to successful administration of receptor antagonists in antimigraine therapy. Ankyrin repeats and kinase domain containing 1 (ANKK1) gene in DRD2 loci is linked to comorbid neurological disorders. Dopamine beta hydroxylase (DBH) is responsible for maintaining dopamine-to-norepinephrine ratio implicated in migraine pathophysiology. Therefore, we aimed to look for association of functional variants in ANKK1 (rs1800497), DRD2 (rs6275 and rs1799732) and DBH (rs7239728 and rs1611115) genes with migraine susceptibility. The present study was carried out in two dependent cohorts (n _primary = 208, n _secondary = 127, n _controls = 200). The results of the cohorts were pooled by meta-analysis using Fisher’s and Mantel–Haenszel test. Benjamini–Hochberg false discovery rate test was used to correct for multiple comparisons. Computer algorithm-based TANGO, WALTZ and LIMBO predictions were used to evaluate the effect of missense polymorphism (rs1800497). For ANKK1 polymorphism, variant genotype and allele showed significant associations with migraine risk. A significant protective effect of variant DRD2 rs6275 polymorphism was noticed. DBH rs7239728 imparted significant risk at genotypic, allelic and carrier analyses. We identified a risk haplotype in DRD2 loci. Two genotype interactions between ANKK1rs1800497 and DBHrs72393728 polymorphisms showed significant risks. The variant gene product of ANKK1 rs1800497 was predicted with decreased aggregation of ANKK1 protein. In conclusion, we identified novel genetic variants, haplotype and gene interactions in dopaminergic pathway as potential risk factors for migraine susceptibility.

Arinami, T., Gao, M., Hamaguchi, H., & Toru, M. (1997). A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Human Molecular Genetics, 6(4), 577–582.PubMedCrossRef

Asuni, C., Cherchi, A., Congiu, D., Piccardi, M. P., Del Zompo, M., & Stochino, M. E. (2007). Association study between clinical response to rizatriptan and some candidate genes. Journal of Headache and Pain, 8(3), 185–189. doi:10.1007/s10194-007-0388-5.PubMedCrossRef

Baldwin, A. S., Jr. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology, 14, 649–683. doi:10.1146/annurev.immunol.14.1.649.PubMedCrossRef

Bontempi, S., Fiorentini, C., Busi, C., Guerra, N., Spano, P., & Missale, C. (2007). Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology, 148(5), 2563–2570. doi:10.1210/en.2006-1618.PubMedCrossRef

Cavestro, C., Rosatello, A., Marino, M. P., Micca, G., & Asteggiano, G. (2006). High prolactin levels as a worsening factor for migraine. Journal of Headache and Pain, 7(2), 83–89. doi:10.1007/s10194-006-0272-8.PubMedCrossRef

Charbit, A. R., Akerman, S., & Goadsby, P. J. (2010). Dopamine: What’s new in migraine? Current Opinion in Neurology, 23(3), 275–281. doi:10.1097/WCO.0b013e3283378d5c.PubMedCrossRef

Craig, S. P., Buckle, V. J., Lamouroux, A., Mallet, J., & Craig, I. W. (1988). Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenetics and Cell Genetics, 48(1), 48–50.PubMedCrossRef

Cubells, J. F., Kranzler, H. R., McCance-Katz, E., Anderson, G. M., Malison, R. T., Price, L. H., et al. (2000). A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Molecular Psychiatry, 5(1), 56–63.PubMedCrossRef

Dichgans, M., Forderreuther, S., Deiterich, M., Pfaffenrath, V., & Gasser, T. (1998). The D2 receptor NcoI allele: Absence of allelic association with migraine with aura. Neurology, 51(3), 928.PubMedCrossRef

Duan, J., Wainwright, M. S., Comeron, J. M., Saitou, N., Sanders, A. R., Gelernter, J., et al. (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Human Molecular Genetics, 12(3), 205–216.PubMedCrossRef

Fernandez, F., Colson, N., Quinlan, S., MacMillan, J., Lea, R. A., & Griffiths, L. R. (2009). Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus. Neurogenetics, 10(3), 199–208. doi:10.1007/s10048-009-0176-2.PubMedCrossRef

Fernandez, F., Lea, R. A., Colson, N. J., Bellis, C., Quinlan, S., & Griffiths, L. R. (2006). Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. Journal of the Neurological Sciences, 251(1–2), 118–123. doi:10.1016/j.jns.2006.09.013.PubMedCrossRef

Fiorentini, C., Guerra, N., Facchetti, M., Finardi, A., Tiberio, L., Schiaffonati, L., et al. (2002). Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. Molecular Endocrinology, 16(2), 353–366.PubMedCrossRef

Garrido, E., Palomo, T., Ponce, G., Garcia-Consuegra, I., Jimenez-Arriero, M. A., & Hoenicka, J. (2011). The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. Neurotoxicity Research, 20(1), 32–39. doi:10.1007/s12640-010-9219-6.PubMedCrossRef

Gotoh, F., Kanda, T., Sakai, F., Yamamoto, M., & Takeoka, T. (1976). Serum dopamine-beta-hydroxylase activity in migraine. Archives of Neurology, 33(9), 656–657.PubMedCrossRef

Grandy, D. K., Litt, M., Allen, L., Bunzow, J. R., Marchionni, M., Makam, H., et al. (1989). The human dopamine D2 receptor gene is located on chromosome 11 at q22–q23 and identifies a TaqI RFLP. American Journal of Human Genetics, 45(5), 778–785.PubMed

Huang, W., Payne, T. J., Ma, J. Z., Beuten, J., Dupont, R. T., Inohara, N., et al. (2009). Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology, 34(2), 319–330. doi:10.1038/npp.2008.37.PubMedCrossRef

Jonsson, E. G., Nothen, M. M., Neidt, H., Forslund, K., Rylander, G., Mattila-Evenden, M., et al. (1999). Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophrenia Research, 40(1), 31–36.PubMedCrossRef

Kelly, A. M., Ardagh, M., Curry, C., D’Antonio, J., & Zebic, S. (1997). Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine. Journal of Accident and Emergency Medicine, 14(4), 209–211.PubMedCrossRef

Launer, L. J., Terwindt, G. M., & Ferrari, M. D. (1999). The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology, 53(3), 537–542.PubMedCrossRef

Lea, R. A., Dohy, A., Jordan, K., Quinlan, S., Brimage, P. J., & Griffiths, L. R. (2000). Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics, 3(1), 35–40.PubMed

Martinez, F., Castillo, J., Pardo, J., Lema, M., & Noya, M. (1993). Catecholamine levels in plasma and CSF in migraine. Journal of Neurology, Neurosurgery and Psychiatry, 56(10), 1119–1121.CrossRef

Maude, S., Curtin, J., Breen, G., Collier, D., Russell, G., Shaw, D., et al. (2001). The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson’s disease. Psychiatric Genetics, 11(1), 49–52.PubMedCrossRef

McCarthy, L. C., Hosford, D. A., Riley, J. H., Bird, M. I., White, N. J., Hewett, D. R., et al. (2001). Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics, 78(3), 135–149. doi:10.1006/geno.2001.6647.PubMedCrossRef

Michaely, P., Tomchick, D. R., Machius, M., & Anderson, R. G. (2002). Crystal structure of a 12 ANK repeat stack from human ankyrinR. EMBO Journal, 21(23), 6387–6396.PubMedCrossRef

Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16(3), 1215.PubMedCrossRef

Neville, M. J., Johnstone, E. C., & Walton, R. T. (2004). Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation, 23(6), 540–545. doi:10.1002/humu.20039.PubMedCrossRef

O’Connor, D. T., Cervenka, J. H., Stone, R. A., Levine, G. L., Parmer, R. J., Franco-Bourland, R. E., et al. (1994). Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: Properties, relationship to central noradrenergic neuronal activity and variation in Parkinson’s disease and congenital dopamine beta-hydroxylase deficiency. Clinical Science (London), 86(2), 149–158.

Peroutka, S. J., Price, S. C., Wilhoit, T. L., & Jones, K. W. (1998). Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Molecular Medicine, 4(1), 14–21.PubMed

Prasad, P., Ambekar, A., & Vaswani, M. (2010). Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: A preliminary study. BMC Medical Genetics, 11, 24. doi:10.1186/1471-2350-11-24.PubMedCrossRef

Rebaudengo, N., Rainero, I., Parziale, A., Rosina, F., Pavanelli, E., Rubino, E., et al. (2004). Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia, 24(6), 503–507. doi:10.1111/j.1468-2982.2004.00689.x.PubMedCrossRef

Tak, P. P., & Firestein, G. S. (2001). NF-kappaB: A key role in inflammatory diseases. Journal of Clinical Investigation, 107(1), 7–11. doi:10.1172/JCI11830.PubMedCrossRef

Tang, Y. L., Epstein, M. P., Anderson, G. M., Zabetian, C. P., & Cubells, J. F. (2007). Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans. European Journal of Human Genetics, 15(8), 878–883. doi:10.1038/sj.ejhg.5201838.PubMedCrossRef

The International Classification of Headache Disorders: 2nd edition (2004). Cephalalgia, 24(Suppl 1), 9–160.

Todt, U., Netzer, C., Toliat, M., Heinze, A., Goebel, I., Nurnberg, P., et al. (2009). New genetic evidence for involvement of the dopamine system in migraine with aura. Human Genetics, 125(3), 265–279. doi:10.1007/s00439-009-0623-z.PubMedCrossRef

Weinshilboum, R., & Axelrod, J. (1971). Serum dopamine-beta-hydroxylase activity. Circulation Research, 28(3), 307–315.PubMedCrossRef

Yealy, D. M. (1994). Acute pain management. Academic Emergency Medicine, 1(2), 186–189.PubMedCrossRef

Titel: Identification of a Novel ANKK1 and Other Dopaminergic (DRD2 and DBH) Gene Variants in Migraine Susceptibility
verfasst von: Jayashri Ghosh
Sunil Pradhan
Balraj Mittal
Publikationsdatum: 01.03.2013
Verlag: Humana Press Inc
Erschienen in: NeuroMolecular Medicine / Ausgabe 1/2013
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-012-8195-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease

Hypobaric Hypoxia and Reoxygenation Induce Proteomic Profile Changes in the Rat Brain Cortex

Composition of Soluble Misfolded Superoxide Dismutase-1 in Murine Models of Amyotrophic Lateral Sclerosis

RVG-Mediated Calpain2 Gene Silencing in the Brain Impairs Learning and Memory

The Identification of Neuropeptide Y Receptor Subtype Involved in Phenylpropanolamine-induced Increase in Oxidative Stress and Appetite Suppression

Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases